Niansen Liu, MD
Psychiatry · Cleveland, TNNPI 1679578371
Payments from drug & device makers
Across 586 payments — averaging $18.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Neurocrine Biosciences, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$910
- Alkermes, Inc.$882
- Takeda Pharmaceuticals U.S.A., Inc.$777
- plus $4K from 20 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 82 | $1,567 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 67 | $1,306 |
| Neurocrine Biosciences, Inc. | 66 | $1,207 |
| Teva Pharmaceuticals USA, Inc. | 53 | $910 |
| Alkermes, Inc. | 44 | $882 |
| Takeda Pharmaceuticals U.S.A., Inc. | 42 | $777 |
| Sunovion Pharmaceuticals Inc. | 41 | $767 |
| Lundbeck LLC | 35 | $688 |
| Vanda Pharmaceuticals Inc. | 29 | $669 |
| AbbVie(2 entities) | 40 | $614 |
| Johnson & Johnson | 22 | $465 |
| Supernus Pharmaceuticals, Inc. | 14 | $274 |
| Almatica Pharma LLC | 9 | $170 |
| Merck | 7 | $119 |
| Idorsia Pharmaceuticals US Inc | 6 | $118 |
| Jazz Pharmaceuticals Inc. | 6 | $110 |
| Harmony Biosciences LLC | 4 | $90 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Eisai Inc. | 4 | $59 |
| Shire North American Group Inc | 3 | $53 |
| E.r. Squibb & Sons, L.L.C. | 2 | $49 |
| Neos Therapeutics, LP | 2 | $36 |
| Bausch Health US, LLC | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| Adlon Therapeutics L.p. | 1 | $14 |
How this compares
$11,093 in reported general payments places this provider in the 90th percentile of 503 psychiatry providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Cleveland
- Rakesh AminNashville$3M
- Brian BonfardinJohnson City$2.6M
- Paul NewhouseNashville$1.4M
- John FenleyJohnson City$1.4M
- Anita VarmaMemphis$1.3M
- Patricia AndrewsNashville$748K
- David SnowMaryville$605K
- Jonathan BeckerBrentwood$261K
- Robert FallisNashville$241K
- James HartFranklin$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.